Please select the option that best describes you:
Topics:
Gynecologic Cancers • Endometrial Cancer
Do you add trastuzumab to adjuvant chemotherapy for patients with Her2+ stage I-II high grade serous uterine cancer following surgical staging?
Or would you reserve its use to stage III-IV or recurrent disease (as in Fader et al., PMID 29584549)?
Answer from: at Community Practice
No, I don’t routinely add trastuzumab to adjuvant chemotherapy for early stage Her2+ serous endometrial cancer patients. There are no data supporting its use in this manner. My recommendation is to offer her treatment on GY026, a study enrolling both early and late-stage serous endometrial can...
Sign in or Register to read more